MIR150, microRNA 150, 406942

N. diseases: 275; N. variants: 0
Source: BEFREE ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.060 Biomarker disease BEFREE However, the role of miR-150 in melanoma remains to be determined. 29690954 2019
CUI: C0025202
Disease: melanoma
melanoma
0.060 Biomarker disease BEFREE Here, we initially showed that microRNA-150-5p (miR-150-5p) inhibits SIX1 expression by directly targeting its 3'-UTR in melanoma cells. miR-150-5p suppressed melanoma cell proliferation, migration, and invasion through inhibition of SIX1. 31128917 2019
CUI: C0025202
Disease: melanoma
melanoma
0.060 Biomarker disease BEFREE In summary, we confirmed the tumor-promoting role of ZFAS1 in melanoma and provide evidence for the role and mechanism of the ZFAS1/miR-150-5p/RAB9A axis. 30889053 2019
CUI: C0025202
Disease: melanoma
melanoma
0.060 AlteredExpression disease BEFREE Utilizing P < 0.0046 as a cutoff to control for one false positive among the 216 miRs revealed that postsurgical melanoma plasma samples had upregulation of miR-1260a (P = 0.0007) and downregulation of miR-150-5p (P = 0.0026) relative to pre-surgical samples. 30132912 2018
CUI: C0025202
Disease: melanoma
melanoma
0.060 Biomarker disease BEFREE The expression level of miR-150 in melanoma tissue and cell lines was detected by reverse transcription-quantitative polymerase chain reaction. miR-150 inhibitors/negative control were transfected into melanoma A375 cells in order to investigate the effects of miR-150 on cell proliferation, apoptosis, cell cycle migration and invasion using a Cell Counting Kit-8, colony formation, Hoechst 33528, flow cytometry, and Transwell assays. 29434838 2018
CUI: C0025202
Disease: melanoma
melanoma
0.060 Biomarker disease BEFREE Finally, of the microRNA in the prognostic model, we found that the expression of a key lymphocyte miRNA, miR-150-5p, which is less abundant in primary melanomas metastatic to brain, correlated with presence of CD45(+) tumor-infiltrating lymphocytes. 26089374 2015